Response to: Prognosis of metastatic bone cancer and myeloma patients and long‑term risk of medication‑related osteonecrosis of the jaw (MRONJ): some critical points
暂无分享,去创建一个
Y. Yamazaki | S. Oizumi | Y. Kitagawa | H. Hata | K. Fujimoto | T. Harabayashi | J. Sato | H. Hiraga | M. Matsuzaka | M. Ueda | Kenji Imamachi | T. Osanai | K. Yoshikawa | M. Takahashi